However, tumor-specific inhibition of glutamine uptake and glutaminase activity in combination with anti-PD-L1 therapy strongly induced CD8+ T cell proliferation and granzyme B production, while abating tumor growth[183]. This evidence concerns the gene CD8A and neoplasm.